We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
An FDA advisory committee unanimously backed FDA approval of Valeant’s Siliq to treat plaque psoriasis, but was split on the risk management of the candidate due to reported suicides. Read More
Chicago is firing back at drugmakers that dismissed the relevance of a high court ruling to the city’s False Claims Act suit against them over their promotion of opioids. Read More
The UK’s drug pricing watchdog has recommended that the National Health Service reimburse for Amgen’s melanoma therapy Imlygic, provided that the company lowers the price. Read More
The FDA is faulting a clinical investigator for neglecting to follow the established procedures for a trial testing a new investigational drug. Read More